Pixalate Releases List of Mobile Apps With the Highest Invalid Traffic (IVT, Including Ad Fraud) in April 2024 Across Google, Apple App Stores: ‘YES Network’, ‘Polys Tiles’ Among Most Impacted
May 24, 2024 11:03 ET
|
Pixalate Inc.
LONDON, May 24, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications
May 24, 2024 03:00 ET
|
Atrogi
STOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of...
Pixalate's Q1 2024 Global Ad Fraud (IVT) Benchmarks for Mobile Apps: $1.4 Billion Spent on Ad Fraud & Invalid Traffic (IVT) Across Apps in the Google and Apple App Stores; IVT Rises 15% YoY
May 23, 2024 14:11 ET
|
Pixalate Inc.
LONDON, May 23, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Global Mobile App Invalid...
Brain Cancer Canada Awards an $80,000 research grant to the development of dual function therapies that harness the body's own immune system to kill brain tumour cells in glioblastomas
May 23, 2024 08:45 ET
|
Brain Cancer Canada
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce $80,000 research grant has been awarded to Dr. Peter Stirling, PhD, Associate Professor at the University of...
UMeWorld Limited Invites Investors to Upcoming Webinar, June 4th at 12PM EST Hosted by CEO Michael Lee to Discuss the Upcoming Acquisition and Relocation
May 23, 2024 08:00 ET
|
UMeWorld Limited
UMeWorld Limited Invites Investors to Upcoming Webinar
Pixalate Releases First Ad Fraud (IVT) Benchmark Reports by Global Region for Connected TV (CTV), Mobile Apps, and Websites: APAC Had Highest Mobile App IVT Rate (30%) in Q1 2024
May 22, 2024 17:21 ET
|
Pixalate Inc.
LONDON, May 22, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Ad Fraud Benchmark Reports by...
Pixalate's Q1 2024 Global Ad Fraud Benchmarks for Connected TV (CTV): $528 Million Spent on Ad Fraud & Invalid Traffic (IVT) Across CTV Platforms Including Roku, Amazon Fire TV, Apple TV, Samsung Smart TV
May 22, 2024 17:00 ET
|
Pixalate Inc.
LONDON, May 22, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Global Connected TV (CTV)...
Pixalate Releases Q1 2024 Global Ad Fraud (IVT) Benchmarks for Desktop & Mobile Web Traffic: 11% IVT Rate on Desktop Web Traffic; Firefox (24%) & Apple’s Safari (20%) Browsers Have Highest IVT Rate
May 22, 2024 16:37 ET
|
Pixalate Inc.
LONDON, May 22, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Global Desktop & Mobile...
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
May 21, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics